Clinical Trials Directory

Trials / Completed

CompletedNCT03571841

Sexual Health and Rehabilitation After Ovarian Suppression Treatment

Sexual Health and Rehabilitation After Ovarian Suppression Treatment (SHARE-OS): An Educational Intervention for Young Breast Cancer Survivors

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This research study is evaluating an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of breast cancer recurrence.

Detailed description

The purpose of this research is to study the effectiveness of an educational intervention for breast cancer survivors who have experienced changes in sexual function after ovarian suppression treatment to reduce the risk of cancer recurrence. The aim is to develop an effective intervention to help women manage these changes and restore sexual health and functioning. \- This study consists of attending a group educational session followed by a one-on-one telephone coaching session. * The group educational session will last about 4 hours, and will include information on resources, self-help strategies, and relaxation techniques. * The telephone coaching session will take place four weeks after the group session, and will last about 15 minutes

Conditions

Interventions

TypeNameDescription
BEHAVIORALGroup SessionThe 4-hour group session will be structured around three 60-minute modules and creation of a personal action plan
BEHAVIORALTelephone BoosterOne month following the group session, women will receive a telephone booster session (\<15 minutes). This brief telephone check-in is intended to help women review progress with their individualized action-plan, problem-solve around continuing problems, and plan for maintenance moving forward.

Timeline

Start date
2018-12-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2018-06-28
Last updated
2021-11-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03571841. Inclusion in this directory is not an endorsement.